Alexion’s Phase III Data Position Ultomiris For Expansion Into Myasthenia Gravis

 
• By Joseph Haas
  
Research scientist
Phase III data might put Alexion closer to adding myasthenia gravis to the Ultomiris label
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D